1. Home
  2. SPOK vs RCEL Comparison

SPOK vs RCEL Comparison

Compare SPOK & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spok Holdings Inc.

SPOK

Spok Holdings Inc.

BUY

Current Price

$12.94

Market Cap

268.2M

ML Signal

BUY

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$3.47

Market Cap

114.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPOK
RCEL
Founded
2004
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
268.2M
114.3M
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
SPOK
RCEL
Price
$12.94
$3.47
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$11.75
AVG Volume (30 Days)
170.7K
202.0K
Earning Date
10-29-2025
11-06-2025
Dividend Yield
9.38%
N/A
EPS Growth
12.68
N/A
EPS
0.80
N/A
Revenue
$139,739,000.00
$72,401,000.00
Revenue This Year
$4.11
$13.12
Revenue Next Year
$2.63
$27.56
P/E Ratio
$16.65
N/A
Revenue Growth
1.47
20.59
52 Week Low
$12.26
$3.25
52 Week High
$19.31
$14.16

Technical Indicators

Market Signals
Indicator
SPOK
RCEL
Relative Strength Index (RSI) 39.04 43.10
Support Level $13.13 $3.25
Resistance Level $13.69 $3.58
Average True Range (ATR) 0.27 0.17
MACD 0.09 0.01
Stochastic Oscillator 6.25 44.00

Price Performance

Historical Comparison
SPOK
RCEL

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: